article 3 months old

Weekly Top Ten News Stories

Weekly Reports | Sep 19 2014

Our top ten news from 11 September 2014 to 18 September 2014 (ranked according to popularity).

Growth Stories Feature For Small Caps
Thursday 11 September 2014 – 10:00 AM

Small cap stocks recovered some ground over August. Brokers delve into the sector to find those stocks holding the most promise.

Uranium Week: Uncertainty Supports Prices
Tuesday 16 September 2014 – 10:00 AM

The spot uranium price continues to rise on uncertainty surrounding strikes, sanctions and start-ups.

Emerging Sell In ANZ
Monday 15 September 2014 – 10:50 AM

Nick Linton-Ffrost of Fifth Wave suggests a short-term trading idea in ANZ Bank.

Chinese Coal Ban: The Losers
Wednesday 17 September 2014 – 01:19 PM

Thermal coal exporters from Australia have been dealt another blow as China says no to lower quality.

Correction Week: This Time IS Different
Wednesday 17 September 2014 – 10:26 AM

Peter Switzer of the Switzer Super Report looks at factors this week which could spark a correction in global stock markets.

Weekly update on recommendation, target price, and earnings forecast changes.

The Short Report
Thursday 11 September 2014 – 11:31 AM

FNArena's weekly update on short positions in the Australian share market.

Under The Hood – September 2014
Wednesday 17 September 2014 – 10:00 AM

In this week's Weekly Insights: – Under The Hood – September 2014 – Crude Oil And The Great Geopolitical Divide – Dividends And The Art Of Looking Forward – AUD Weakness: Winners & Losers – BHP Billiton And Support At 4% Yield – Buy-Backs Rule – Rudi On TV: The W

Material Matters: Platinum, Palladium, Gold And Iron Ore
Monday 15 September 2014 – 01:42 PM

Platinum and palladium supply remain weak while gold companies are concentrating on profitable ounces and risks around iron ore are not receding.

10 CSL's Monopoly Now Threatened
Tuesday 16 September 2014 – 12:23 PM

CSL's competitor, Baxter, has received US FDA approval for HyQvia and brokers assess the impact on CSL's rival product, Hizentra.

Share on FacebookTweet about this on TwitterShare on LinkedIn

Click to view our Glossary of Financial Terms